Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathwaysQiang Zhang, Ning Kang, Shijie Cao et al.|Biomedicine & Pharmacotherapy|2020Cited by 214
Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut MicrobiotaSa Yang, Ning Kang|Frontiers in Pharmacology|2022Cited by 50